Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Carcinoma, Renal Cell × 30 days × Clear all

Phase

Status

Recruiting 45 Active not recruiting 22 Not yet recruiting 9 Terminated 8 Completed 6 Suspended 2 Withdrawn 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 5 Prostatic Neoplasms 3 Triple Negative Breast Neoplasms 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Neoplasms 2 Myelodysplastic Syndromes 2 Leukemia 2 Kidney Neoplasms 2 Colorectal Neoplasms 2 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Urologic Neoplasms 1 Urinary Incontinence 1 Squamous Cell Carcinoma of Head and Neck 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycystic Ovary Syndrome 1 Pain 1 Motor Activity 1 Mesothelioma, Malignant 1 Mesothelioma 1 Melanoma 1 Lymphedema 1 Lung Neoplasms 1 Liver Neoplasms 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Acute 1 Leukemia, Biphenotypic, Acute 1 Influenza, Human 1 Improving Fecal Immunochemical Test (FIT) Completion Rates 1 Esophageal Squamous Cell Carcinoma 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07284953 2026-03-13

PuraBond

The Royal Wolverhampton Hospitals NHS Trust

Phase NA Withdrawn

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡